ARAY (Accuray) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


ARAY Accuray Inc ARAY
40 GF Score
Price $0.31
GF Value $1.34
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Accuray Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Accuray's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

ARAY vs PAVM, BDMD, TELA: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, Accuray's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accuray Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accuray's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Accuray's Margin of Safety % (DCF Earnings Based) falls into.


ARAY
40GF Score
Accuray Inc ARAY
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Accuray (ARAY) Overvalued in 2026?

Based on GuruFocus' analysis, Accuray stock appears to be undervalued. The current stock price of $0.31 is trading 76.8% below its estimated GF Value™ of $1.34. GuruFocus considers Accuray to be Possible Value Trap.

Key valuation signals for ARAY:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $1.34 vs. price of $0.31 (76.8% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the ARAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Accuray Business Description

Other Exchanges 0H8I:UKXEJ:Germany
Address 1240 Deming Way, Madison, WI, USA, 53717
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
40GF Score

Get the complete analysis for ARAY

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.31
Price
$1.34
GF Value